Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula
Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Feb 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the risk of hand problems, known as ischaemia, that can occur after a specific surgery called an arteriovenous fistula creation. This surgery is often needed for patients with severe kidney disease, particularly those who require dialysis. The researchers want to understand how certain changes in blood vessels and other clinical factors might be linked to these problems in the short or medium term after the surgery.
To participate in this study, individuals must be at least 18 years old and have stage 5 chronic kidney disease, whether or not they are on dialysis. They should also need an arteriovenous fistula for treatment. The trial is not yet recruiting participants, so it’s important to keep an eye on updates if someone is interested. Participants will be monitored and expected to attend scheduled visits to help researchers gather important information. Potential participants should be aware that those with certain medical conditions or who are pregnant will not be eligible for the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years;
- • Stage 5 chronic kidney disease, on dialysis or not on dialysis;
- • Requiring the creation of an arteriovenous fistula;
- • Membership of a social insurance scheme;
- • Patient having been informed and having formulated his/her oral non-opposition to participate in the research.
- Exclusion Criteria:
- • Contraindication to the proposed surgery ;
- • Reduced life expectancy in the opinion of the investigator;
- • Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient;
- • Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre;
- • Other surgical or medical intervention planned during the study;
- • Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
- • Participating in another clinical trial, or in a period of exclusion from another clinical trial;
- • Patient under guardianship or deprived of liberty.
About Gcs Ramsay Santé Pour L'enseignement Et La Recherche
GCS Ramsay Santé pour l'Enseignement et la Recherche is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and education. As a collaborative group, it unites academic institutions and healthcare professionals to facilitate high-quality clinical trials that enhance patient care and contribute to medical knowledge. With a focus on rigorous scientific standards and ethical practices, GCS Ramsay Santé plays a crucial role in the development of new therapies and treatment protocols, ensuring that cutting-edge research translates into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported